Comparison of efficacy and safety of azilsartan and olmesartan in patients with essential hypertension
Phase of Trial: Phase II
Latest Information Update: 31 May 2017
At a glance
- Drugs Azilsartan (Primary) ; Olmesartan medoxomil
- Indications Essential hypertension
- Focus Therapeutic Use
- Acronyms CANZONE study
- 24 Mar 2016 Status changed from recruiting to completed.
- 20 Apr 2015 According to the University Hospital Medical Information Network - Japan record, planned number of patients changed from 80 to 60.
- 20 Jan 2015 New trial record